ACTI-BILE MD
Natural health product licensed in Canada
- Licence holder
- Acti-Bile (1987) Inc.
- NPN or DIN-HM
- 00810398
- Status
- Active licence
- Licence date
- 5 December 2007
- Revision date
- 16 September 2020
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de bile Source : Bovine Extraction ratio : 1:1 Dry plant equivalent : 50 mg | 50 mg | Not calculated |
| Artichaut Source : Partie aérienne du plante Extraction ratio : 1:4 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Sodium oleate | 50 mg | Not calculated |
| Peumus boldus Source : Feuille(s) Extraction ratio : 1:4 Dry plant equivalent : 60 mg | 15 mg | Not calculated |
| Sulfate de magnésium | 10 mg | Not calculated |
Non-medicinal ingredients
Sambucus canadensis, Fumaria officinalis, Bardane, Raphanus sativus var. niger, Malva sylvestris, Zingiber officinale, Cnicus benedictus, Trigonella foenum-graecum, Foeniculum vulgare, Apium graveolens, Povidone, Juniperus communis, Amidon, Armoracia rusticana, Silybum marianum, cellulose, Urtica dioica, Rosmarinus officinalis, Verbena officinalis, Stellaria media
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Cholagogue, lipotrope. Comme agent cholagogue, il favorise l'évacuation de la bile et facilite la digestion des substances grasses.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé avant l'utilisation si vous avez des calculs biliaires ou une obstruction du canal cholédoque. Consulter un praticien de soins de santé si les symptômes persistent. Garder hors de la portée des enfants.
- Contre-indications
Ne pas utiliser en cas de grossesse ou d'allaitement. Ne pas utiliser si vous souffrez d'une maladie de reins. Ne pas utiliser si vous souffrez d'une maladie du foie. Ne pas utiliser en cas d'allergie à la famille des astéracées ou composées (marguerite jaune)
Source
Official Health Canada record, licence 00810398
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging